AngioDynamics, Inc. (NASDAQ: ANGO), a leading medical technology company dedicated to enhancing vascular health and expanding cancer treatment options, has announced the launch of the RECOVER-AV trial. This prospective, multicenter, multinational, single-arm study will evaluate the efficacy, safety, and long-term…
Topline Results from TROPION-Breast01 Phase 3 Trial of Datopotamab Deruxtecan The TROPION-Breast01 phase 3 trial evaluating datopotamab deruxtecan (Dato-DXd) against investigator’s choice chemotherapy has reported that while the treatment met its primary endpoint for progression-free survival (PFS), it did not…
Genentech, part of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced positive topline results from the Phase III CENTERSTONE study of Xofluza® (baloxavir marboxil). The study showed that a single oral dose of Xofluza significantly reduced the transmission of…
Prolucent®, a top provider of healthcare workforce optimization solutions, is excited to announce two key new hires to boost market expansion and sales growth. Jason Phibbs has been appointed Vice President of Growth, and Darryl Green will take on the…
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company specializing in cancer and autoimmune disease treatments, has received approval to conduct a clinical trial for its BCL2 inhibitor, ICP-248, in combination with azacitidine for acute myeloid leukemia (AML) in…
Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company specializing in bioelectronic medicine, announced it has received Institutional Review Board (IRB) approval from The Feinstein Institutes for the next phase of clinical work on its non-invasive cervical vagus nerve…
Aura, a leader in personalized healthcare, has launched a groundbreaking at-home health check in New York. In just one hour, nurses conduct extensive blood work, imaging, cognitive assessments, and more, all from the comfort of your home. This holistic approach…
Alzprotect, a French biopharma company, has successfully completed the open-label extension (OLE) phase of its Phase 2a trial for AZP2006 (ezeprogind®) in treating Progressive Supranuclear Palsy (PSP). Results from the 6-month extension highlight AZP2006’s potential to stabilize or slow disease…
Axion BioSystems and STEMCELL Technologies are excited to announce a strategic partnership that will see STEMCELL distributing Axion’s advanced Maestro Pro™ and Maestro Edge™ multielectrode array (MEA) systems across North America and Europe. The Maestro MEA systems will also remain…
Novostia, a leading medical technology company advancing a groundbreaking heart valve replacement, has announced a leadership change and secured CHF 5.6 million in funding. Soad El Ghazouani has been appointed as the new CEO, taking over from Alain Barbal, who…
Life Spine, Inc., a medical device company specializing in products for spinal disorder treatments, announced that the international peer-reviewed journal Spine has published a new study comparing discectomy performance during Transforaminal Lumbar Interbody Fusion (TLIF) using an endoscopic technique versus…
MATTER, a leading healthcare incubator and innovation hub, has been selected by the Biomedical Advanced Research and Development Authority (BARDA) as the Digital Health Hub for the BARDA Accelerator Network. BARDA, part of the U.S. Department of Health and Human…